Dr. Daniel DeAngelo, MD, PhD
Claim this profileDana Farber Cancer Institute
Affiliated Hospitals
Dana Farber Cancer Institute
Dana Farber Cancer Institute Harvard Cancer Center
Clinical Trials Daniel DeAngelo, MD, PhD is currently running
Venetoclax + Chemotherapy
for Leukemia
This research study is studying a medication called Venetoclax and a chemotherapy regimen as a possible treatment for Acute Lymphoblastic Leukemia. The drugs involved in this study are: * Venetoclax * Standard Chemotherapy (which includes cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, 6-mercaptopurine, etoposide, and cytarabine
Recruiting
3 awards
Phase 1 & 2
Avapritinib + Decitabine
for Systemic Mastocytosis
Systemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a challenging disease to treat. Targeted KIT inhibitors have been approved for this indication based on their ability to control the mastocytosis portion of the disease, but patients frequently experience progression of the concomitant myeloid malignancy (i.e. the AHN). Using a combination approach to treat both aspects of the disease has the potential to provide enhanced disease control; however, overlapping toxicity is a concern. In this study, investigators aim to study the safety and tolerability of combined avapritinib and decitabine for the treatment of SM-AHN.
Recruiting
1 award
Phase 1
More about Daniel DeAngelo, MD, PhD
Clinical Trial Related
8 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Daniel DeAngelo, MD, PhD has experience with
- Venetoclax
- Azacitidine
- Avapritinib
- IMGN632
- Calaspargase Pegol
- Siremadlin
Breakdown of trials Daniel DeAngelo, MD, PhD has run
Acute Myeloid Leukemia
Relapse
Acute Lymphoblastic Leukemia
Acute T-Cell Leukemia
Systemic Mastocytosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel DeAngelo, MD, PhD specialize in?
Daniel DeAngelo, MD, PhD focuses on Acute Myeloid Leukemia and Relapse. In particular, much of their work with Acute Myeloid Leukemia has involved CD123 positive patients, or patients who are undergoing treatment.
Is Daniel DeAngelo, MD, PhD currently recruiting for clinical trials?
Yes, Daniel DeAngelo, MD, PhD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Daniel DeAngelo, MD, PhD has studied deeply?
Yes, Daniel DeAngelo, MD, PhD has studied treatments such as Venetoclax, Azacitidine, Avapritinib.
What is the best way to schedule an appointment with Daniel DeAngelo, MD, PhD?
Apply for one of the trials that Daniel DeAngelo, MD, PhD is conducting.
What is the office address of Daniel DeAngelo, MD, PhD?
The office of Daniel DeAngelo, MD, PhD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.